R

esearchers at Massachusetts Eye and Ear were stumped when they saw T cells in the retinas of mice with glaucoma, so they called in an immunologist. Now their collaboration has produced the intriguing conclusion that glaucoma might be an autoimmune disease.

In a paper released Friday, they reported that T cells, key soldiers in the immune system’s defense against microbes, play a role in the prolonged retinal degeneration seen in glaucoma. They also identified the target of the T cells: heat shock proteins, manufactured by both human cells and the bacteria residing within us.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • This research has all the hallmarks of the probability that the outcome results that are advanced in the thesis and the research that is replicated exactly the same way, with the data that are the same across the board at probably the most significant aspect of the topic than has ever before been revealed, until this research has been established as authentic with the hypotheses confirmed. I applaud the researchers’ who were able to provide their outcome that does indeed confirm the hypothesis and makes the research valid in the development of what has now become a confirmed theory. Amazing and hopefully the end of the tragic experience of one who has lost their visual acuity.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy